Treatment With Ziprasidone for Schizophrenia Patients With Obsessive Compulsive Disorder (OCD)

Sheba Medical Center45 enrolled

Overview

Comparing schizophrenic patients with comorbid OCD and schizophrenic patients without OCD in response to Ziprasidone and in cognitive functioning as compared with OCD patients

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

DIAGNOSTIC

Masking

SINGLE

Enrollment

Conditions

Schizophrenia Obsessive Compulsive Disorder

Interventions

ZiprasidoneDRUG

40-80 mg BID

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Diagnosis of Schizophrenia and OCD for at least 6 months * Minimum score of 14 on YBOCS * Minimum score of 60 on PANSS * Diagnosis of Schizophrenia without OC symptoms Exclusion Criteria: * Patients who are already being treated with ziprasidone * Diagnosis of schizophreniform disorder * Organic brain syndrome, mental retardation and pervasive developmental disorder * Patients having any significantly cardiovascular illness or electrolyte imbalance

Locations (1)

Chaim Sheba Medical Center

Ramat Gan, Israel

Outcomes

Primary Outcomes

YBOCS

Time frame: 8 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.